My Top 3 Healthcare Stocks to Buy in 2026

02:37pm, Saturday, 13'th Dec 2025
With its diverse product line, AbbVie is a terrific dividend stock with a solid underlying business. Eli Lilly is growing its top line incredibly rapidly and expanding into other therapeutic areas.
Eli Lilly, United Airlines and Urban Outfitters lead five stocks that are showing strength, near buy points, as AI stocks struggle.
AQR Capital Management LLC lowered its stake in Eli Lilly and Company (NYSE: LLY) by 38.9% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 346,975 shares of
BlueCrest Capital Management Ltd acquired a new stake in Eli Lilly and Company (NYSE: LLY) during the second quarter, according to its most recent filing with the SEC. The firm acquired 9,337 shares o
Blue Capital Inc. purchased a new stake in Eli Lilly and Company (NYSE: LLY) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commissio

Eli Lilly: The Right Long-Term Strategy

04:33am, Saturday, 13'th Dec 2025
Eli Lilly is positioned for a secular growth trajectory, leveraging its duopoly in diabetes and obesity therapies while investing heavily in pipeline diversification. LLY faces intensifying competitio
Ameriprise Financial Inc. lowered its holdings in Eli Lilly and Company (NYSE: LLY) by 1.4% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commi

My Top 10 Stocks to Buy for 2026

04:10am, Saturday, 13'th Dec 2025
Together, these stocks offer you a balanced mix of growth and safety. These companies span a number of industries, and many are leaders in their markets.
Bamco Inc. NY grew its stake in shares of Eli Lilly and Company (NYSE: LLY) by 200.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The in
Eli Lilly (LLY) reached $1 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.
Eli Lilly and Co shared updated results of Inluriyo (imlunestrant) from a Phase 3 study in previously treated breast cancer patients.
LLY's retatrutide posts strong weight-loss and pain-reduction results in its first Phase III study, boosting investor optimism.
As monotherapy, imlunestrant demonstrated an 11.4-month numeric improvement in median OS versus endocrine therapy in patients with ESR1-mutated disease In all patients, the imlunestrant plus abemacicl
On Friday, Europe's drug regulator recommended extending the use of Eli Lilly's type 2 diabetes drug, Mounjaro, to children as young as 10.
From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%, before taking a breather and then heading higher.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE